Recombinant multi-species ABL T315I protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ABL T315I protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is a protooncogene that encodes a protein tyrosine kinase involved in a variety of cellular processes, including cell division, adhesion, differentiation, and response to stress. The activity of the protein is negatively regulated by its SH3 domain, whereby deletion of the region encoding this domain results in an oncogene. The ubiquitously expressed protein has DNA-binding activity that is regulated by CDC2-mediated phosphorylation, suggesting a cell cycle function. This gene has been found fused to a variety of translocation partner genes in various leukemias, most notably the t(9;22) translocation that results in a fusion with the 5' end of the breakpoint cluster region gene (BCR; MIM:151410). Alternative splicing of this gene results in two transcript variants, which contain alternative first exons that are spliced to the remaining common exons. [provided by RefSeq, Aug 2014]
The Alternative Names of target: ABL,ABL T315I,ABL1,Abelson murine leukemia viral oncogene homolog 1,Abelson tyrosine-protein kinase 1,Abl,Abl1,BCR-ABL,CHDSKM,E430008G22Rik,JTK7,Proto-oncogene c-Abl,Tyrosine-protein kinase ABL1,bcr/abl,c-ABL,c-ABL1,c-Abl,p150,v-abl
Go
to ABL T315I products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T00348-Ag-1/ GM-Tg-hg-T00348-Ag-2 | Human ABL T315I protein | Human |
| GM-Tg-rg-T00348-Ag-1/ GM-Tg-rg-T00348-Ag-2 | Rat ABL T315I protein | Rat |
| GM-Tg-mg-T00348-Ag-1/ GM-Tg-mg-T00348-Ag-2 | Mouse ABL T315I protein | Mouse |
| GM-Tg-cynog-T00348-Ag-1/ GM-Tg-cynog-T00348-Ag-2 | Cynomolgus/Rhesus macaque ABL T315I protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T00348-Ag-1/ GM-Tg-felg-T00348-Ag-2 | Feline ABL T315I protein | Feline |
| GM-Tg-cang-T00348-Ag-1/ GM-Tg-cang-T00348-Ag-2 | Canine ABL T315I protein | Canine |
| GM-Tg-bovg-T00348-Ag-1/ GM-Tg-bovg-T00348-Ag-2 | Bovine ABL T315I protein | Bovine |
| GM-Tg-equg-T00348-Ag-1/ GM-Tg-equg-T00348-Ag-2 | Equine ABL T315I protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T00348-Ag-1/ GM-Tg-hg-T00348-Ag-2;
GM-Tg-rg-T00348-Ag-1/ GM-Tg-rg-T00348-Ag-2;
GM-Tg-mg-T00348-Ag-1/ GM-Tg-mg-T00348-Ag-2; GM-Tg-cynog-T00348-Ag-1/ GM-Tg-cynog-T00348-Ag-2; GM-Tg-felg-T00348-Ag-1/ GM-Tg-felg-T00348-Ag-2; GM-Tg-cang-T00348-Ag-1/ GM-Tg-cang-T00348-Ag-2; GM-Tg-bovg-T00348-Ag-1/ GM-Tg-bovg-T00348-Ag-2; GM-Tg-equg-T00348-Ag-1/ GM-Tg-equg-T00348-Ag-2 |
| Products Name | ABL T315I protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | ABL T315I |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ABL T315I protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.